name: mRNA gene expression profiling by quantitative real-time polymerase chain reaction (RT-PCR), 17 genes (15 target and 2 reference genes) in whole blood specimen, reported as continuous risk score and classification of inflammatory bowel disease aggressiveness


name: Oncology (thyroid), mRNA, gene expression analysis of 593 genes (including BRAF, RAS, RET, PAX8, and NTRK) for sequence variants and rearrangements, utilizing fine needle aspirate, reported as detected or not detected


name: mRNA gene analysis of 539 genes in fine needle aspiration thyroid specimen, reported as detected or not detected


name: mRNA gene expression analysis of 593 genes (including BRAF, RAS, RET, PAX8, and NTRK) for sequence variants and rearrangements in fine needle aspirate thyroid specimen, reported as detected or not detected


name: Ophthalmology (age-related macular degeneration), analysis of 3 gene variants (2 CFH gene, 1 ARMS2 gene), using PCR and MALDI-TOF, buccal swab, reported as positive or negative for neovascular age-related macular-degeneration risk associated with zinc supplements


name: Gene analysis for detection of variants in 3 genes in cheek swab specimen for neovascular age-related macular-degeneration risk associated with zinc supplements


name: Gene analysis of 3 gene variants (2 CFH gene, 1 ARMS2 gene), using polymerase chain reaction (PCR) and matrix-assisted laser desorption ionization time of flight (MALDI-TOF) in buccal swab specimen, reported as positive or negative for neovascular age-related macular-degeneration risk associated with zinc supplements


name: Neurology (Alzheimer disease); cell aggregation using morphometric imaging and protein kinase C-epsilon (PKCe) concentration in response to amylospheroid treatment by ELISA, cultured skin fibroblasts, each reported as positive or negative for Alzheimer disease


name: Cell aggregation testing of cultured skin cells for Alzheimer disease, reported as positive or negative for Alzheimer disease


name: Cell aggregation using morphometric imaging and protein kinase C-epsilon (PKCe) concentration in response to amylospheroid treatment by enzyme-linked immunosorbent assay (ELISA), in cultured skin fibroblasts, each reported as positive or negative for Alzheimer disease


name: Neurology (Alzheimer disease); quantitative imaging of phosphorylated ERK1 and ERK2 in response to bradykinin treatment by in situ immunofluorescence, using cultured skin fibroblasts, reported as a probability index for Alzheimer disease (List separately in addition to code for primary procedure)


name: Immunofluorescence testing of cultured skin cells for Alzheimer disease, reported as probability index for Alzheimer disease


name: Quantitative imaging of phosphorylated ERK1 and ERK2 in response to bradykinin treatment by in situ immunofluorescence, using cultured skin fibroblasts, reported as probability index for Alzheimer disease


name: Cytogenomic constitutional (genome-wide) analysis, interrogation of genomic regions for copy number, structural changes and areas of homozygosity for chromosomal abnormalities


name: Cytogenomic analysis of whole genome for abnormal chromosomes


name: Cytogenomic constitutional analysis with interrogation of genomic regions for copy number, structural changes and areas of homozygosity for chromosomal abnormalities


name: Syphilis test, non-treponemal antibody, immunoassay, quantitative (RPR)


name: Measurement of nontreponemal antibodies associated with syphilis


name: Syphilis test by detection of non-treponemal antibody by immunoassay using rapid plasma reagin (RPR)


name: Oncology (pan-tumor), DNA and RNA by next-generation sequencing, utilizing formalin-fixed paraffin-embedded tissue, interpretative report for single nucleotide variants, copy number alterations, tumor mutational burden, and microsatellite instability, with therapy association


name: Next-generation sequencing of DNA and RNA in tumor tissue specimen with interpretative report


name: Next-generation DNA and RNA sequencing in tissue specimen, interpretative report for single nucleotide variants, copy number alterations, tumor mutational burden, and microsatellite instability, with therapy association


name: Rare diseases (constitutional/heritable disorders), whole genome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, proband


name: Rare diseases genetic testing of complete DNA of first affected person in family


name: Whole genome and mitochondrial DNA sequence analysis for rare disease, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in blood sample from proband


name: Whole genome and mitochondrial DNA sequence analysis for rare disease, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in saliva sample from proband


name: Rare diseases (constitutional/heritable disorders), whole genome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, each comparator genome (eg, parent, sibling)


name: Rare diseases genetic testing of complete DNA of relative of affected person in family


name: Whole genome and mitochondrial DNA sequence analysis for rare disease, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in comparator blood sample from parent of proband


name: Whole genome and mitochondrial DNA sequence analysis for rare disease, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in comparator blood sample from relative of proband


name: Whole genome and mitochondrial DNA sequence analysis for rare disease, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in comparator blood sample from sibling of proband


name: Whole genome and mitochondrial DNA sequence analysis for rare disease, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in comparator saliva sample from relative of proband


name: Rare diseases (constitutional/heritable disorders), whole exome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, proband


name: Rare diseases genetic testing of protein coding genes of first affected person in family


name: Whole exome and mitochondrial DNA sequence analysis for rare disease, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in blood sample from proband


name: Whole exome and mitochondrial DNA sequence analysis for rare disease, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in saliva sample from proband


name: Rare diseases (constitutional/heritable disorders), whole exome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, each comparator exome (eg, parent, sibling)


name: Rare diseases genetic testing of protein coding genes of relative of affected person in family


name: Whole exome and mitochondrial DNA sequence analysis for rare disease, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in blood sample from parent of proband


name: Whole exome and mitochondrial DNA sequence analysis for rare disease, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in blood sample from relative of proband


name: Whole exome and mitochondrial DNA sequence analysis for rare disease, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in saliva sample from parent of proband


name: Whole exome and mitochondrial DNA sequence analysis for rare disease, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in saliva sample from relative of proband


name: Neurology (inherited ataxias), genomic DNA sequence analysis of 12 common genes including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants


name: DNA analysis of gene sequence of 12 genes for identification and characterization of abnormalites associated with inherited disorders of movement (ataxia)


name: Genomic DNA sequence of 12 common genes associated with inherited ataxia, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in blood specimen, with identification and categorization of genetic variants


name: Genomic DNA sequence of 12 common genes associated with inherited ataxia, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in saliva specimen, with identification and categorization of genetic variants


name: Neurology (inherited ataxias), genomic DNA sequence analysis of 51 genes including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants


name: DNA analysis of gene sequence of 51 genes for identification and characterization of abnormalites associated with inherited disorders of movement (ataxia)


name: Genomic DNA sequence of 51 genes associated with inherited ataxia, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in blood specimen, with identification and categorization of genetic variants


name: Genomic DNA sequence of 51 genes associated with inherited ataxia, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in saliva specimen, with identification and categorization of genetic variants


name: Neurology (muscular dystrophy), DMD gene sequence analysis, including small sequence changes, deletions, duplications, and variants in non-uniquely mappable regions, blood or saliva, identification and characterization of genetic variants


name: DNA analysis of gene sequence for identification and characterization of abnormalites associated with muscular dystrophy


name: Duschenne muscular dystrophy (DMD gene sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in blood specimen, with identification and categorization of genetic variants


name: Duschenne muscular dystrophy (DMD gene sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, in saliva specimen, with identification and categorization of genetic variants


name: Infectious agent (human immunodeficiency virus), targeted viral next-generation sequence analysis (ie, protease [PR], reverse transcriptase [RT], integrase [INT]), algorithm reported as prediction of antiviral drug susceptibility


name: Gene analysis of human immunodeficiency virus targeted sequence analysis for resistance to antiviral drugs


name: Targeted next-generation protease (PR), reverse transcriptase (RT), integrase (INT) sequence analysis of human immunodeficiency virus, algorithm reported as prediction of antiviral drug susceptibility


name: Oncology (breast cancer), image analysis with artificial intelligence assessment of 12 histologic and immunohistochemical features, reported as a recurrence score


name: Image analysis of breast cancer cell specimen with artificial intelligence assessment


name: Image analysis of breast cancer with artificial intelligence assessment of 12 histologic and immunohistochemical features, reported as recurrence score


name: Red cell antigen (ABO blood group) genotyping (ABO), gene analysis, next-generation sequencing, ABO (ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase) gene


name: Red blood cell antigen genotyping, ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase gene next generation sequencing


name: ABO blood group red cell antigen genotyping, ABO alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase (ABO) next-generation sequencing


name: Red cell antigen (RH blood group) genotyping (RHD and RHCE), gene analysis, next-generation sequencing, RH proximal promoter, exons 1-10, portions of introns 2-3


name: Red blood cell antigen genotyping, RH proximal promoter, exons 1-10, portions of introns 2-3


name: RH blood group red cell antigen genotyping (RHD and RHCE), next-generation sequencing of RH proximal promoter, exons 1-10, portions of introns 2-3


name: Detection of respiratory tract pathogen nucleic acid in nasopharyngeal swab specimen by qualitative real-time polymerase chain reaction (TR-PCR), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), each pathogen reported as detected or not detected


name: Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), includes titer(s), when performed


name: Measurement of antibody to severe acute respiratory syndrome coronavirus 2 (COVID-19)


name: Measurement of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody, including titers


name: Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), amplified probe technique, including multiplex reverse transcription for RNA targets, each analyte reported as detected or not detected


name: Test for detection of respiratory disease-causing organisms, 21 target organisms including severe acute respiratory syndrome coronavirus 2 (COVID-19)


name: Detection of respiratory disease infectious agent DNA and RNA, 21 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by amplified probe technique with multiplex reverse transcription for RNA targets, reported as detected or not detected


name: Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), ELISA, plasma, serum


name: Surrogate viral neutralization test (sVNT) for detection of antibodies to severe acute respiratory syndrome coronavirus 2 (Covid-19) by


name: Surrogate viral neutralization test (sVNT) for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in plasma specimen by enzyme-linked immunosorbent assay (ELISA)


name: Surrogate viral neutralization test (sVNT) for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in serum specimen by enzyme-linked immunosorbent assay (ELISA)


name: Administration of first or only component of each toxoid via any route with counseling by other qualified health care professional, patient 18 years of age or younger


name: Administration of first or only component of each toxoid via any route with counseling by physician, patient 18 years of age or younger


name: Administration of first or only component of each vaccine via any route with counseling by other qualified health care professional, patient 18 years of age or younger


name: Administration of first or only component of each vaccine via any route with counseling by physician, patient 18 years of age or younger


name: Administration of each additional toxoid component via any route with counseling by other qualified health care professional, patient 18 years of age or younger


name: Administration of each additional toxoid component via any route with counseling by physician, patient 18 years of age or younger


name: Administration of each additional vaccine component via any route with counseling by other qualified health care professional, patient 18 years of age or younger


name: Administration of each additional vaccine component via any route with counseling by physician, patient 18 years of age or younger


name: Intranasal administration of each additional combination toxoid


name: Intranasal administration of each additional combination vaccine


name: Intranasal administration of each additional single toxoid


name: Intranasal administration of each additional single vaccine


name: Intraoral administration of each additional combination toxoid


name: Intraoral administration of each additional combination vaccine


name: Intraoral administration of each additional single toxoid


name: Intraoral administration of each additional single vaccine


name: Adenovirus vaccine, type 4, live, for oral use (procedure)


name: Adenovirus vaccine, type 7, live, for oral use (procedure)


name: Live Bacillus Calmette-Guerin (BCG) vaccine, for percutaneous use


name: Live Bacillus Calmette-Guerin (BCG) vaccine, for intravesical use


name: Meningococcal recombinant lipoprotein vaccine, serogroup B (MenB-FHbp), 2 dose schedule, for intramuscular use


name: Meningococcal recombinant lipoprotein vaccine, serogroup B (MenB-FHbp), 3 dose schedule, for intramuscular use


name: Cholera vaccine, adult dosage, single dose schedule, for oral use


name: Hepatitis A (HepA) vaccine, adolescent dosage, 2 dose schedule, for intramuscular use


name: Hepatitis A (HepA) vaccine, pediatric dosage, 2 dose schedule, for intramuscular use


name: Hepatitis A (HepA) vaccine, adolescent dosage, 3 dose schedule, for intramuscular use


name: Hepatitis A (HepA) vaccine, pediatric dosage, 3 dose schedule, for intramuscular use


name: Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, and 58, nonavalent (9vHPV), 2 dose schedule, for intramuscular use


name: Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, and 58, nonavalent (9vHPV), 3 dose schedule, for intramuscular use


name: Inactivated adjuvanted influenza virus vaccine(IIV), for intramuscular use


name: Influenza virus vaccine, derived from cell cultures, subunit, preservative and antibiotic free, trivalent (ccIIV3), for intramuscular use


name: Influenza vaccine, quadrivalent for nasal administration


name: Live preservative-free influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, for intramuscular use


name: Diphtheria and tetanus (DT) toxoids adsorbed, patient younger than 7 years of age, for intramuscular use


name: Inactivated poliovirus vaccine (IPV), for intramuscular use


name: Inactivated poliovirus vaccine (IPV), for subcutaneous use


name: Preservative free tetanus and diphtheria (Td) adsorbed toxoids, patient 7 years of age or older, for intramuscular use


name: Diphtheria, tetanus toxoids, and acellular pertussis (Tdap) vaccine, patient 7 years of age or older


name: Pneumococcal polysaccharide vaccine, 23-valent (PPSV23), adult or immunosuppressed patient dosage, patient 2 years of age or older, for intramuscular use


name: Pneumococcal polysaccharide vaccine, 23-valent (PPSV23), adult or immunosuppressed patient dosage, patient 2 years of age or older, for subcutaneous use


name: Meningococcal conjugate vaccine, serogroups A, C, Y and W-135 quadrivalent (MCV4 or MenACWY), for intramuscular use


name: Hepatitis B (HepB) vaccine, dialysis patient dosage, 3 dose schedule, for intramuscular use


name: Hepatitis B (HepB) vaccine, immunosuppressed patient dosage, 3 dose schedule, for intramuscular use


name: Hepatitis B (HepB) vaccine, adolescent dosage, 3 dose schedule, for intramuscular use


name: Hepatitis B (HepB) vaccine, pediatric dosage, 3 dose schedule, for intramuscular use


name: Hepatitis B (HepB) vaccine, dialysis patient dosage, 4 dose schedule, for intramuscular use


name: Hepatitis B (HepB) vaccine, immunosuppressed patient dosage, 4 dose schedule, for intramuscular use


name: Psychotherapy with evaluation and management visit, 45 minutes


name: Psychotherapy for crisis, each additional 30 minutes


name: Family psychotherapy with patient present, 50 minutes


name: Pharmacological management with prescription and review of medication, and psychotherapy service


name: Narcosynthesis for psychiatric diagnostic and therapeutic purposes


name: Initial delivery and management of therapeutic repetitive transcranial magnetic stimulation (TMS) treatment with cortical mapping and motor threshold determination


name: Subsequent delivery and management of therapeutic repetitive transcranial magnetic stimulation (TMS) treatment, per session


name: Subsequent motor threshold redetermination with delivery and management of therapeutic repetitive transcranial magnetic stimulation (TMS) treatment


name: Individual psychophysiological therapy incorporating biofeedback training by any modality, face-to-face with the patient, with psychotherapy, 30 minutes


name: Individual psychophysiological therapy incorporating biofeedback training by any modality, face-to-face with the patient, with psychotherapy, 45 minutes


name: Biofeedback training of anorectal sphincter with electromyography (EMG) and manometry, initial 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of anorectal sphincter with electromyography (EMG) and manometry, initial 15 minutes of one-on-one physician contact with patient


name: Biofeedback training of anorectal sphincter with electromyography (EMG), initial 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of anorectal sphincter with electromyography (EMG), initial 15 minutes of one-on-one physician contact with patient


name: Biofeedback training of anorectal sphincter with manometry, initial 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of anorectal sphincter with manometry, initial 15 minutes of one-on-one physician contact with patient


name: Biofeedback training of anorectal sphincter, initial 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of anorectal sphincter, initial 15 minutes of one-on-one physician contact with patient


name: Biofeedback training of perineal muscles with electromyography (EMG) and manometry, initial 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of perineal muscles with electromyography (EMG) and manometry, initial 15 minutes of one-on-one physician contact with patient


name: Biofeedback training of perineal muscles with electromyography (EMG), initial 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of perineal muscles with electromyography (EMG), initial 15 minutes of one-on-one physician contact with patient


name: Biofeedback training of perineal muscles with manometry, initial 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of perineal muscles with manometry, initial 15 minutes of one-on-one physician contact with patient


name: Biofeedback training of perineal muscles, initial 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of perineal muscles, initial 15 minutes of one-on-one physician contact with patient


name: Biofeedback training of urethral sphincter with electromyography (EMG) and manometry, initial 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of urethral sphincter with electromyography (EMG) and manometry, initial 15 minutes of one-on-one physician contact with patient


name: Biofeedback training of urethral sphincter with electromyography (EMG), initial 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of urethral sphincter with electromyography (EMG), initial 15 minutes of one-on-one physician contact with patient


name: Biofeedback training of urethral sphincter with manometry, initial 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of urethral sphincter with manometry, initial 15 minutes of one-on-one physician contact with patient


name: Biofeedback training of urethral sphincter, initial 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of urethral sphincter, initial 15 minutes of one-on-one physician contact with patient


name: Biofeedback training of anorectal sphincter with electromyography (EMG) and manometry, each additional 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of anorectal sphincter with electromyography (EMG), each additional 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of anorectal sphincter with manometry, each additional 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of anorectal sphincter, each additional 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of perineal muscles with electromyography (EMG) and manometry, each additional 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of perineal muscles with electromyography (EMG), each additional 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of perineal muscles with manometry, each additional 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of perineal muscles, each additional 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of urethral sphincter with electromyography (EMG), each additional 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of urethral sphincter with manometry, each additional 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of urethral sphincter with with electromyography (EMG) and manometry, each additional 15 minutes of one-on-one other qualified health care professional contact with patient


name: Biofeedback training of urethral sphincter, each additional 15 minutes of one-on-one other qualified health care professional contact with patient


name: Hemodialysis procedure with single evaluation by other qualified health care professional


name: Dialysis procedure (other than hemodialysis) with single evaluation by other qualified health care professional


name: End-stage renal disease (ESRD) related monthly services with monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents, patient younger than 2 years of age, with 4 or more face-to-face visits per month


name: End-stage renal disease (ESRD) related monthly services with monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents, patient younger than 2 years of age, with 2-3 face-to-face visits per month


name: End-stage renal disease (ESRD) related monthly services with monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents, patient younger than 2 years of age, with single face-to-face visit per month


name: End-stage renal disease (ESRD) related monthly services with monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents, patient 2-11 years of age, with 4 or more face-to-face visits per month


name: End-stage renal disease (ESRD) related monthly services with monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents, patient 2-11 years of age, with 2-3 face-to-face visits per month


name: End-stage renal disease (ESRD) related monthly services with monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents, patient 2-11 years of age, with single face-to-face visit per month


name: End-stage renal disease (ESRD) related monthly services with monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents, patient 12-19 years of age, with 4 or more face-to-face visits per month


name: End-stage renal disease (ESRD) related monthly services with monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents, patient 12-19 years of age, with 2-3 face-to-face visits per month


name: End-stage renal disease (ESRD) related monthly services with monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents, patient 12-19 years of age, with 1 face-to-face visit per month


name: End-stage renal disease (ESRD) related monthly services, patient 20 years of age or older, with 4 or more face-to-face visits per month


name: End-stage renal disease (ESRD) related monthly services, patient 20 years of age or older, with 2-3 face-to-face visits per month


name: End-stage renal disease (ESRD) related monthly services, patient 20 years of age or older, with single face-to-face visit per month


name: End-stage renal disease (ESRD) related monthly services with monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents, patient younger than 2 years of age


name: End-stage renal disease (ESRD) related monthly services with monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents, patient 2-11 years of age


name: End-stage renal disease (ESRD) related monthly services with monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents, patient 12-19 years of age


name: End-stage renal disease (ESRD) related monthly services, patient 20 years of age or older


name: End-stage renal disease (ESRD) related services less than a full month of service, per day, patient younger than 2 years of age


name: End-stage renal disease (ESRD) related services less than a full month of service, per day, patient 2-11 years of age


name: End-stage renal disease (ESRD) related services less than a full month of service, per day, patient 12-19 years of age


name: End-stage renal disease (ESRD) related services less than a full month of service, per day, patient 20 years of age or older


name: Dialysis training including helper, completed course


name: Dialysis training including helper, course not completed


name: Gastroesophageal junction study with perfusion, with interpretation and report


name: Gastroesophageal junction study with stimulation, with interpretation and report


name: Manometric study of the esophagus and gastroesophageal junction study with perfusion, with interpretation and report


name: Manometric study of the esophagus and gastroesophageal junction study with stimulation, with interpretation and report


name: Manometric study of the esophagus with perfusion, with interpretation and report


name: Manometric study of the esophagus with stimulation, with interpretation and report


name: Prolonged (more than 1 hour, less than 24 hours) gastroesophageal reflux test of esophagus with nasal catheter intraluminal impedance electrodes placement, recording, analysis and interpretation


name: Diagnostic esophageal balloon distension provocation study


name: Diagnostic esophageal balloon distension study


name: Intraluminal gastrointestinal tract imaging of esophagus through ileum, with interpretation and report


name: Intraluminal gastrointestinal tract imaging of esophagus with interpretation and report


name: Gastrointestinal tract transit and pressure measurement from stomach to colon using wireless capsule with interpretation and report


name: Colon manometric study with provocation tests, minimum of 6 hours continuous reading with interpretation and report


name: New patient ophthalmological intermediate medical examination and evaluation with initiation of diagnostic and treatment program


name: Ophthalmological comprehensive medical examination and initiation of diagnostic and treatment program for new patient, multiple visits


name: Ophthalmological comprehensive medical examination and initiation of diagnostic and treatment program for new patient, single visit


name: Ophthalmological intermediate medical examination and continuation of diagnostic and treatment program for established patient


name: Ophthalmological comprehensive medical examination with continuation of diagnostic and treatment program for established patient, multiple visits


name: Ophthalmological comprehensive medical examination with continuation of diagnostic and treatment program for established patient, single visit


name: Ophthalmological comprehensive medical examination with initiation of diagnostic and treatment program for established patient, multiple visits


name: Ophthalmological comprehensive medical examination with initiation of diagnostic and treatment program for established patient, single visit


name: Complete ophthalmological examination and evaluation under general anesthesia


name: Complete ophthalmological examination and evaluation under general anesthesia with manipulation of globe for passive range of motion to facilitate diagnostic examination


name: Complete ophthalmological examination and evaluation under general anesthesia with other manipulation to facilitate diagnostic examination


name: Limited ophthalmological examination and evaluation under general anesthesia


name: Limited ophthalmological examination and evaluation under general anesthesia with manipulation of globe for passive range of motion to facilitate diagnostic examination


name: Limited ophthalmological examination and evaluation under general anesthesia with other manipulation to facilitate diagnostic examination


name: Initial fitting of contact lens for management of keratoconus


name: Limited bilateral visual field examination with interpretation and report


name: Limited unilateral visual field examination with interpretation and report


name: Intermediate bilateral visual field examination with interpretation and report


name: Intermediate unilateral visual field examination with interpretation and report


name: Extended bilateral visual field examination with interpretation and report


name: Extended unilateral visual field examination with interpretation and report


name: Serial tonometry with multiple measurements of intraocular pressure over an extended time period on the same day with interpretation and report


name: Imaging of retina for detection or monitoring of disease


name: Bilateral imaging of retina for detection of disease with remote clinical staff review and report


name: Bilateral imaging of retina for monitoring of disease with remote clinical staff review and report


name: Unilateral imaging of retina for detection of disease with remote clinical staff review and report


name: Unilateral imaging of retina for monitoring of disease with remote clinical staff review and report


name: Bilateral imaging of retina for detection of active renal disease with remote healthcare professional review, interpretation, and report


name: Bilateral imaging of retina for monitoring of active renal disease with remote healthcare professional review, interpretation, and report


name: Unilateral imaging of retina for detection of active renal disease with remote healthcare professional review, interpretation, and report


name: Unilateral imaging of retina for monitoring of active renal disease with remote healthcare professional review, interpretation, and report


name: Imaging of retina for detection or monitoring of disease; point-of-care autonomous analysis and report, unilateral or bilateral


name: Imaging of retina for disease detection, with automated review and report at point of care


name: Bilateral fluorescein angiography with multiframe imaging, interpretation, and report


name: Unilateral fluorescein angiography with multiframe imaging, interpretation, and report


name: Bilateral indocyanine-green angiography with multiframe imaging, interpretation, and report


name: Unilateral indocyanine-green angiography with multiframe imaging, interpretation, and report


name: Bilateral fluorescein and indocyanine-green angiography with multiframe imaging, interpretation, and report


name: Unilateral fluorescein and indocyanine-green angiography with multiframe imaging, interpretation, and report


name: Needle oculoelectromyography extraocular muscles of both eyes with interpretation and report


name: Needle oculoelectromyography extraocular muscles of single eye with interpretation and report


name: Full field electroretinography (ERG) with interpretation and report


name: Multifocal electroretinography (mfERG) with interpretation and report


name: External ocular photography with interpretation and report for documentation of medical progress


name: Anterior segment imaging with specular microscopy and endothelial cell analysis with interpretation and report


name: Anterior segment imaging with fluorescein angiography with interpretation and report


name: Prescription of optical and physical characteristics of and fitting of corneal contact lens, both eyes, with medical supervision of adaptation


name: Prescription of optical and physical characteristics of and fitting of corneal contact lens for aphakia, single eye, with medical supervision of adaptation


name: Prescription of optical and physical characteristics of and fitting of corneal contact lens for aphakia, both eyes, with medical supervision of adaptation


name: Prescription of optical and physical characteristics of and fitting of corneoscleral contact lens, with medical supervision of adaptation


name: Prescription of optical and physical characteristics of and fitting of corneal contact lens, both eyes, with medical supervision of adaptation and direction of fitting by independent technician


name: Prescription of optical and physical characteristics of and fitting of corneal contact lens for aphakia, single eye, with medical supervision of adaptation and direction of fitting by independent technician


name: Prescription of optical and physical characteristics of and fitting of corneal contact lens for aphakia, both eyes, with medical supervision of adaptation and direction of fitting by independent technician


name: Prescription of optical and physical characteristics of and fitting of corneoscleral contact lens, with medical supervision of adaptation and direction of fitting by independent technician


name: fitting multifocal spectacles, except for aphakia


name: Fitting of multifocal spectacles (other than bifocal)


name: fitting monofocal spectacles for aphakia


name: fitting multifocal spectacles for aphakia


name: Fitting of single element system spectacle prosthesis


name: Fitting of compound lens system spectacle aid


name: Repair and refitting spectacles for aphakia


name: Treatment of auditory processing disorder for individual


name: Treatment of speech, language, voice, and communication disorder for individual


name: Treatment of speech, language, voice, communication, and auditory processing disorder for individual


name: Treatment of auditory processing disorder for multiple individuals


name: Treatment of speech, language, voice, and communication disorder for multiple individuals


name: Treatment of speech, language, voice, communication, and auditory processing disorder for multiple individuals


name: Vestibular evoked myogenic potential (VEMP) testing, with interpretation and report


name: Vestibular evoked myogenic potential (VEMP) testing, with interpretation and report; cervical (cVEMP)


name: VEMP testing of lower branch of inner ear nerve with interpretation and report


name: Cervical vestibular evoked myogenic potential (cVEMP) testing, with interpretation and report


name: Vestibular evoked myogenic potential (VEMP) testing, with interpretation and report; ocular (oVEMP)


name: VEMP testing of upper branch of inner ear nerve with interpretation and report


name: Ocular vestibular evoked myogenic potential (oVEMP) testing, with interpretation and report


name: Vestibular evoked myogenic potential (VEMP) testing, with interpretation and report; cervical (cVEMP) and ocular (oVEMP)


name: VEMP testing of upper and lower branches of inner ear nerve with interpretation and report


name: Cervical and ocular vestibular evoked myogenic potential (cVEMP and oVEMP) testing, with interpretation and report


name: Bilateral bithermal caloric vestibular test with recording


name: Bilateral monothermal caloric vestibular test with recording


name: Basic vestibular evaluation with oscillating tracking test with recording


name: Basic vestibular evaluation with spontaneous nystagmus test with recording


name: Spontaneous nystagmus test with recording


name: Bidirectional foveal stimulation optokinetic nystagmus test with recording


name: Bidirectional peripheral stimulation optokinetic nystagmus test with recording


name: Computerized dynamic posturography sensory organization test (CDP-SOT) for 6 conditions, with interpretation and report


name: Computerized dynamic posturography sensory organization test (CDP-SOT) for 6 conditions, with motor control test and adaptation test, with interpretation and report


name: Caloric vestibular test, each irrigation


name: Automated evoked otoacoustic emissions screening


name: Acoustic immittance testing with tympanometry, acoustic reflex threshold testing, and acoustic reflex decay testing


name: Limited evaluation of distortion product evoked otoacoustic emissions with interpretation and report


name: Transient evoked otoacoustic emissions with interpretation and report


name: Comprehensive diagnostic evaluation of distortion product evoked otoacoustic emissions, with interpretation and report


name: Auditory evoked potentials; screening of auditory potential with broadband stimuli, automated analysis


name: Screening evaluation of brain response to sound with automated analysis


name: Auditory evoked potentials using broadband stimuli for screening of auditory potential, with automated analysis


name: Auditory evoked potentials; for hearing status determination, broadband stimuli, with interpretation and report


name: Evaluation of brain response to sound for determination of hearing status with interpretation and report


name: Auditory evoked potentials using broadband stimuli for hearing status determination, with interpretation and report


name: Auditory evoked potentials; for threshold estimation at multiple frequencies, with interpretation and report


name: Evaluation of brain response to sound for determination of hearing threshold with interpretation and report


name: Auditory evoked potentials for threshold estimation at multiple frequencies, with interpretation and report


name: Auditory evoked potentials; neurodiagnostic, with interpretation and report


name: Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report


name: Diagnostic analysis of cochlear implant with programming, patient younger than 7 years of age


name: Diagnostic analysis of cochlear implant with subsequent programming, patient younger than 7 years of age


name: Diagnostic analysis of cochlear implant with programming, patient 7 years of age or older


name: Diagnostic analysis of cochlear implant with subsequent programming, patient 7 years of age or older


name: Evaluation for prescription of nonspeech-generating augmentative and alternative communication device, face-to-face with patient, first hour


name: Evaluation for prescription of nonspeech-generating augmentative and alternative communication device, face-to-face with patient, each additional 30 minutes


name: Therapeutic services for the use of non-speech-generating device with programming and modification


name: Evaluation for prescription for speech-generating augmentative and alternative communication device, face-to-face with patient, first hour


name: Evaluation for prescription for speech-generating augmentative and alternative communication device, face-to-face with patient, each additional 30 minutes


name: Therapeutic services for the use of speech-generating device with programming and modification


name: Flexible endoscopic evaluation of swallowing by cine recording


name: Flexible endoscopic evaluation of swallowing by video recording


name: Interpretation and report only of flexible endoscopic evaluation of swallowing by cine recording


name: Interpretation and report only of flexible endoscopic evaluation of swallowing by video recording


name: Flexible endoscopic evaluation, laryngeal sensory testing by cine recording


name: Flexible endoscopic evaluation, laryngeal sensory testing by video recording


name: Interpretation and report only of flexible endoscopic evaluation, laryngeal sensory testing by cine recording


name: Interpretation and report only of flexible endoscopic evaluation, laryngeal sensory testing by video recording


name: Flexible endoscopic evaluation of swallowing and laryngeal sensory testing by cine recording


name: Flexible endoscopic evaluation of swallowing and laryngeal sensory testing by video recording


name: Interpretation and report only of flexible endoscopic evaluation of swallowing and laryngeal sensory testing by cine recording


name: Interpretation and report only of flexible endoscopic evaluation of swallowing and laryngeal sensory testing by video recording


name: Evaluation of central auditory function with report, initial 60 minutes


name: Evaluation of central auditory function with report, each additional 15 minutes


name: Evaluation of auditory function for postopertative status of a surgically implanted device, first hour


name: Evaluation of auditory function for postoperative status of surgically implanted device, each additional 15 minutes


name: Evaluation of auditory function for surgically implanted device candidacy, each additional 15 minutes


name: Auditory rehabilitation for prelingual hearing loss


name: Auditory rehabilitation for postlingual hearing loss


name: Percutaneous transluminal coronary angioplasty into single major coronary artery


name: Percutaneous transluminal coronary angioplasty into single major coronary branch


name: Percutaneous transluminal coronary angioplasty into each additional branch of a major coronary artery


name: Percutaneous transluminal coronary atherectomy into single major coronary artery


name: Percutaneous transluminal coronary atherectomy into single major coronary branch


name: Percutaneous transluminal coronary atherectomy with angioplasty into single major coronary artery


name: Percutaneous transluminal coronary atherectomy with angioplasty into single major coronary branch


name: Percutaneous transluminal coronary atherectomy into each additional branch of a major coronary artery


name: Percutaneous transluminal coronary atherectomy with angioplasty into each additional branch of a major coronary artery


name: Percutaneous transcatheter insertion of stent into single major coronary artery


name: Percutaneous transcatheter insertion of stent with coronary angioplasty into single major coronary artery


name: Percutaneous transcatheter insertion of stent into each additional branch of a major coronary artery


name: Percutaneous transcatheter insertion of stent with coronary angioplasty into each additional branch of a major coronary artery


name: Percutaneous transluminal coronary atherectomy with angioplasty and insertion of stent into single major coronary artery


name: Percutaneous transluminal coronary atherectomy with angioplasty and insertion of stent into single major coronary branch


name: Percutaneous transluminal coronary atherectomy with insertion of stent into single major coronary artery


name: Percutaneous transluminal coronary atherectomy with insertion of stent into single major coronary branch


name: Percutaneous transluminal coronary atherectomy with angioplasty and insertion of stent into each additional branch of a major coronary artery


name: Percutaneous transluminal coronary atherectomy with insertion of stent into each additional branch of a major coronary artery


name: Percutaneous transluminal revascularization of a single coronary artery bypass graft with angioplasty


name: Percutaneous transluminal revascularization of a single coronary artery bypass graft with angioplasty and insertion of stent


name: Percutaneous transluminal revascularization of a single coronary artery bypass graft with atherectomy


name: Percutaneous transluminal revascularization of a single coronary artery bypass graft with atherectomy and angioplasty


name: Percutaneous transluminal revascularization of a single coronary artery bypass graft with atherectomy and insertion of stent


name: Percutaneous transluminal revascularization of a single coronary artery bypass graft with atherectomy, angioplasty, and insertion of stent


name: Percutaneous transluminal revascularization of a single coronary artery bypass graft with insertion of stent


name: Percutaneous transluminal revascularization of each additional branch subtended by the coronary artery bypass graft with angioplasty and insertion of stent


name: Percutaneous transluminal revascularization of each additional branch subtended by the coronary artery bypass graft with atherectomy and insertion of stent


name: Percutaneous transluminal revascularization of each additional branch subtended by the coronary artery bypass graft with atherectomy, angioplasty and insertion of stent


name: Percutaneous transluminal revascularization of acute subtotal occlusion of a single coronary artery bypass graft with atherectomy, angioplasty, and insertion of stent


name: Percutaneous transluminal revascularization of acute subtotal occlusion of a single coronary artery with atherectomy, angioplasty, and insertion of stent


name: Percutaneous transluminal revascularization of acute total occlusion of a single coronary artery bypass graft with atherectomy, angioplasty, and insertion of stent


name: Percutaneous transluminal revascularization of acute total occlusion of a single coronary artery with atherectomy, angioplasty, and insertion of stent


name: Percutaneous transluminal revascularization of chronic total occlusion of a single coronary artery branch with atherectomy, angioplasty, and insertion of stent


name: Percutaneous transluminal revascularization of chronic total occlusion of a single coronary artery bypass graft with atherectomy, angioplasty, and insertion of stent


name: Percutaneous transluminal revascularization of chronic total occlusion of a single coronary artery with atherectomy, angioplasty, and insertion of stent


name: Percutaneous transluminal revascularization of each additional coronary artery branch with atherectomy, angioplasty, and insertion of stent


name: Percutaneous transluminal revascularization of each additional coronary artery bypass graft with atherectomy, angioplasty, and insertion of stent


name: Percutaneous transluminal revascularization of each additional coronary artery with atherectomy, angioplasty, and insertion of stent


name: Coronary thrombolysis by intracoronary infusion with selective coronary angiography


name: Intravascular ultrasound (IVUS) of coronary graft during diagnostic evaluation and therapeutic intervention with imaging supervision, interpretation and report, initial vessel


name: Intravascular ultrasound (IVUS) of coronary graft during diagnostic evaluation with imaging supervision, interpretation and report, initial vessel


name: Intravascular ultrasound (IVUS) of coronary graft during therapeutic intervention with imaging supervision, interpretation and report, initial vessel


name: Intravascular ultrasound (IVUS) of coronary vessel during diagnostic evaluation and therapeutic intervention with imaging supervision, interpretation and report, initial vessel


name: Intravascular ultrasound (IVUS) of coronary vessel during diagnostic evaluation with imaging supervision, interpretation and report, initial vessel


name: Intravascular ultrasound (IVUS) of coronary vessel during therapeutic intervention with imaging supervision, interpretation and report, initial vessel


name: Optical coherence tomography (OCT) of coronary graft during diagnostic evaluation and therapeutic intervention with imaging supervision, interpretation and report, initial vessel


name: Optical coherence tomography (OCT) of coronary graft during diagnostic evaluation with imaging supervision, interpretation and report, initial vessel


name: Optical coherence tomography (OCT) of coronary graft during therapeutic intervention with imaging supervision, interpretation and report, initial vessel


name: Optical coherence tomography (OCT) of coronary vessel during diagnostic evaluation and therapeutic intervention with imaging supervision, interpretation and report, initial vessel


name: Optical coherence tomography (OCT) of coronary vessel during diagnostic evaluation with imaging supervision, interpretation and report, initial vessel


name: Optical coherence tomography (OCT) of coronary vessel during therapeutic intervention with imaging supervision, interpretation and report, initial vessel


name: Intravascular ultrasound (IVUS) of coronary graft during diagnostic evaluation and therapeutic intervention with imaging supervision, interpretation and report, each additional vessel


name: Intravascular ultrasound (IVUS) of coronary graft during diagnostic evaluation with imaging supervision, interpretation and report, each additional vessel


name: Intravascular ultrasound (IVUS) of coronary graft during therapeutic intervention with imaging supervision, interpretation and report, each additional vessel


name: Intravascular ultrasound (IVUS) of coronary vessel during diagnostic evaluation and therapeutic intervention with imaging supervision, interpretation and report, each additional vessel


name: Intravascular ultrasound (IVUS) of coronary vessel during diagnostic evaluation with imaging supervision, interpretation and report, each additional vessel


name: Intravascular ultrasound (IVUS) of coronary vessel during therapeutic intervention with imaging supervision, interpretation and report, each additional vessel


name: Optical coherence tomography (OCT) of coronary graft during diagnostic evaluation and therapeutic intervention with imaging supervision, interpretation and report, each additional vessel


name: Optical coherence tomography (OCT) of coronary graft during diagnostic evaluation with imaging supervision, interpretation and report, each additional vessel


name: Optical coherence tomography (OCT) of coronary graft during therapeutic intervention with imaging supervision, interpretation and report, each additional vessel


name: Optical coherence tomography (OCT) of coronary vessel during diagnostic evaluation and therapeutic intervention with imaging supervision, interpretation and report, each additional vessel


name: Optical coherence tomography (OCT) of coronary vessel during diagnostic evaluation with imaging supervision, interpretation and report, each additional vessel


name: Optical coherence tomography (OCT) of coronary vessel during therapeutic intervention with imaging supervision, interpretation and report, each additional vessel


name: External elective electrical conversion of arrhythmia


name: Internal elective electrical conversion of arrhythmia


name: Routine electrocardiogram (ECG) with interpretation and report, 12 or more leads


name: Tracing only of routine electrocardiogram (ECG), 12 or more leads


name: Interpretation and report only of routine electrocardiogram (ECG), 12 or more leads


name: Cardiovascular stress test with supervision, interpretation, and report


name: Cardiovascular stress test with supervision


name: Tracing only of cardiovascular stress test with supervision


name: Interpretation and report only of cardiovascular stress test


name: Rhythm electrocardiogram (ECG) with interpretation and report, 1-3 leads


name: Tracing only of rhythm electrocardiogram (ECG), 1-3 leads


name: Noninvasive upper extremity arterial pressure waveform analysis with assessment of central arterial pressure, interpretation, and report


name: Recording, scanning analysis with report, other qualified health care professional review and interpretation of external electrocardiographic recording up to 48 hours by continuous rhythm recording and storage


name: Other qualified health care professional review and interpretation of external electrocardiographic recording up to 48 hours by continuous rhythm recording and storage


name: Other qualified health care professional review and interpretation with report of external mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis, and greater than 24 hours of accessible electrocardiogram (ECG) data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days


name: Physician review and interpretation with report of external mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis, and greater than 24 hours of accessible electrocardiogram (ECG) data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days


name: Technical support for connection and patient instructions for use, attended surveillance for up to 30 days, analysis and other qualified health care professional prescribed transmission of daily and emergent data reports of external mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis, and greater than 24 hours of accessible electrocardiogram (ECG) data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center


name: Technical support for connection and patient instructions for use, attended surveillance for up to 30 days, analysis and physician prescribed transmission of daily and emergent data reports of external mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis, and greater than 24 hours of accessible electrocardiogram (ECG) data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center


name: External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage


name: External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; includes recording, scanning analysis with report, review and interpretation


name: Heart rhythm recording, analysis, report, review, and interpretation of continous external EKG over more than 48 hours up to 7 days


name: Recording, scanning analysis with report, review and interpretation for external electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage


name: External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; recording (includes connection and initial recording)


name: Heart rhythm recording continous external EKG over more than 48 hours up to 7 days


name: Connection and recording for external electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage


name: External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; scanning analysis with report


name: Heart rhythm analysis and report of continous external EKG over more than 48 hours up to 7 days


name: Scanning analysis and report for external electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage


name: External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; review and interpretation


name: Heart rhythm review, and interpretation of continous external EKG over more than 48 hours up to 7 days


name: Review and interpretation for external electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage


name: External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage


name: External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; includes recording, scanning analysis with report, review and interpretation


name: Heart rhythm recording, analysis, interpretation and report of continous external EKG over more than 1 week up to 1 weeks


name: Recording, scanning analysis with report, review and interpretation for external electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage


name: External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording)


name: Heart rhythm recording of continous external EKG over 8-15 days


name: Connection and initial recording for external electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage


name: External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; scanning analysis with report


name: Heart rhythm analysis and report of continous external EKG over 8-15 days


name: Scanning analysis and report for external electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage


name: External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation


name: Heart rhythm review and interpretation of continous external EKG over 8-15 days


name: Review and interpretation for external electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage


name: Transmission, other qualified health care professional review and interpretation of external patient and auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring


name: Transmission, other qualified health care professional review and interpretation of external patient with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring


name: Transmission, physician review and interpretation of external patient and auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring


name: Transmission, physician review and interpretation of external patient with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring


name: Recording of external patient and auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring


name: Recording of external patient with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring


name: Transmission and analysis of external patient and auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring


name: Transmission and analysis of external patient with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring


name: Other qualified health care professional review and interpretation of external patient and auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring


name: Other qualified health care professional review and interpretation of external patient with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring


name: Physician review and interpretation of external patient and auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring


name: Physician review and interpretation of external patient with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring


name: Signal-averaged electrocardiography (SAECG), with electrocardiogram (ECG)


name: Programming device evaluation and adjustment of implantable subcutaneous lead defibrillator system with other qualified health care professional analysis, reviews, and report


name: Programming device evaluation in person of leadless pacemaker system in single chamber of heart with iterative adjustment, analysis, review, and report by other qualified health care professional


name: Programming device evaluation in person of leadless pacemaker system in single chamber of heart with iterative adjustment, analysis, review, and report by physician


name: Programming device evaluation of single lead pacemaker system in person with iterative adjustment, analysis, review, and report by other qualified health care professional


name: Programming device evaluation of single lead pacemaker system in person with iterative adjustment, analysis, review, and report by physician


name: Programming device evaluation in person with iterative adjustment of the implantable device with other qualified health care professional analysis, review, and report for dual lead pacemaker system


name: Programming device evaluation in person with iterative adjustment of the implantable device with other qualified health care professional analysis, review, and report for multiple lead pacemaker system


name: Programming device evaluation in person with iterative adjustment of the implantable device with other qualified health care professional analysis, review, and report for single lead implantable cardioverter-defibrillator system


name: Programming device evaluation in person with iterative adjustment of the implantable device with other qualified health care professional analysis, review, and report for dual lead implantable cardioverter-defibrillator system


name: Programming device evaluation in person with iterative adjustment of the implantable device with other qualified health care professional analysis, review, and report for multiple lead implantable cardioverter-defibrillator system


name: Programming device evaluation in person of subcutaneous cardiac rhythm monitor system with iterative adjustment, analysis, review, and report by other qualified health care professional


name: Programming device evaluation in person of subcutaneous cardiac rhythm monitor system with iterative adjustment, analysis, review, and report by physician


name: Evaluation of implantable subcutaneous lead defibrillator system with analysis, review, and report performed by other qualified health care professional


name: Evaluation of implantable subcutaneous lead defibrillator system with analysis, review, and report performed by physician


name: Interrogation device evaluation in person of dual lead pacemaker system with analysis, review, and report by other qualified health care professional


name: Interrogation device evaluation in person of dual lead pacemaker system with analysis, review, and report by physician


name: Interrogation device evaluation in person of multiple lead pacemaker system with analysis, review, and report by other qualified health care professional


name: Interrogation device evaluation in person of multiple lead pacemaker system with analysis, review, and report by physician


name: Interrogation device evaluation in person of single lead pacemaker system with analysis, review, and report by other qualified health care professional


name: Interrogation device evaluation in person of single lead pacemaker system with analysis, review, and report by physician


name: Interrogation device evaluation in person with other qualified health care professional analysis, review, and report, includes connection, recording, and disconnection per patient encounter for dual lead implantable cardioverter-defibrillator system, with analysis of heart rhythm derived data elements


name: Interrogation device evaluation in person with other qualified health care professional analysis, review, and report, includes connection, recording, and disconnection per patient encounter for multiple lead implantable cardioverter-defibrillator system, with analysis of heart rhythm derived data elements


name: Interrogation device evaluation in person with other qualified health care professional analysis, review, and report, includes connection, recording, and disconnection per patient encounter for single lead implantable cardioverter-defibrillator system, with analysis of heart rhythm derived data elements


name: Interrogation device evaluation in person with physician analysis, review, and report, includes connection, recording, and disconnection per patient encounter for dual lead implantable cardioverter-defibrillator system, with analysis of heart rhythm derived data elements


name: Interrogation device evaluation in person with physician analysis, review, and report, includes connection, recording, and disconnection per patient encounter for multiple lead implantable cardioverter-defibrillator system, with analysis of heart rhythm derived data elements


name: Interrogation device evaluation in person with physician analysis, review, and report, includes connection, recording, and disconnection per patient encounter for single lead implantable cardioverter-defibrillator system, with analysis of heart rhythm derived data elements


name: Interrogation device evaluation in person of implantable cardiovascular monitor system with analysis, review, and report, with analysis of multiple recorded physiologic cardiovascular data elements from internal and external sensors, by other qualified health care professional


name: Interrogation device evaluation in person of implantable cardiovascular monitor system with analysis, review, and report, with analysis of multiple recorded physiologic cardiovascular data elements from internal and external sensors, by physician


name: Interrogation device evaluation in person of implantable cardiovascular monitor system with analysis, review, and report, with analysis of single recorded physiologic cardiovascular data element from internal and external sensors, by other qualified health care professional


name: Interrogation device evaluation in person of implantable cardiovascular monitor system with analysis, review, and report, with analysis of single recorded physiologic cardiovascular data element from internal and external sensors, by physician


name: Interrogation device evaluation in person of subcutaneous cardiac rhythm monitor system with analysis, review, and report, with analysis of heart rhythm derived data, by other qualified health care professional


name: Interrogation device evaluation in person of subcutaneous cardiac rhythm monitor system with analysis, review, and report, with analysis of heart rhythm derived data, by physician


name: Interrogation device evaluation in person with other qualified health care professional analysis, review, and report, includes connection, recording, and disconnection per patient encounter of wearable defibrillator system


name: Remote monitoring of wireless pulmonary artery pressure sensor for up to 30 days with interpretation, trend analysis, and report by other qualified health care professional


name: Remote monitoring of wireless pulmonary artery pressure sensor for up to 30 days with interpretation, trend analysis, and report by physician


name: Periprocedural device evaluation in person and programming of dual lead pacemaker system with analysis, review, and report by other qualified health care professional


name: Periprocedural device evaluation in person and programming of dual lead pacemaker system with analysis, review, and report by physician


name: Periprocedural device evaluation in person and programming of multiple lead pacemaker system with analysis, review, and report by other qualified health care professional


name: Periprocedural device evaluation in person and programming of multiple lead pacemaker system with analysis, review, and report by physician


name: Periprocedural device evaluation in person of single lead pacemaker system with programming, analysis, review, and report by other qualified health care professional


name: Periprocedural device evaluation in person of single lead pacemaker system with programming, analysis, review, and report by physician


name: Periprocedural device evaluation in person and programming of device system parameters before or after a surgery, procedure, or test with other qualified health care professional analysis, review, and report for dual lead implantable cardioverter-defibrillator system


name: Periprocedural device evaluation in person and programming of device system parameters before or after a surgery, procedure, or test with other qualified health care professional analysis, review, and report for multiple implantable cardioverter-defibrillator system


name: Periprocedural device evaluation in person and programming of device system parameters before or after a surgery, procedure, or test with other qualified health care professional analysis, review, and report for single lead implantable cardioverter-defibrillator system


name: Periprocedural device evaluation in person and programming of device system parameters before or after a surgery, procedure, or test with physician analysis, review, and report for dual lead implantable cardioverter-defibrillator system


name: Periprocedural device evaluation in person and programming of device system parameters before or after a surgery, procedure, or test with physician analysis, review, and report for multiple implantable cardioverter-defibrillator system


name: Periprocedural device evaluation in person and programming of device system parameters before or after a surgery, procedure, or test with physician analysis, review, and report for single lead implantable cardioverter-defibrillator system


name: Transtelephonic rhythm strip pacemaker evaluations of dual lead pacemaker system, with recording up to 90 days with and without magnet application with other qualified health care professional analysis, review, and reports


name: Transtelephonic rhythm strip pacemaker evaluations of dual lead pacemaker system, with recording up to 90 days with and without magnet application with physician analysis, review, and reports


name: Transtelephonic rhythm strip pacemaker evaluations of multiple lead pacemaker system, with recording up to 90 days with and without magnet application with other qualified health care professional analysis, review, and reports


name: Transtelephonic rhythm strip pacemaker evaluations of multiple lead pacemaker system, with recording up to 90 days with and without magnet application with physician analysis, review, and reports


name: Transtelephonic rhythm strip pacemaker evaluations of single lead pacemaker system, with recording up to 90 days with and without magnet application with other qualified health care professional analysis, review, and reports


name: Transtelephonic rhythm strip pacemaker evaluations of single lead pacemaker system, with recording up to 90 days with and without magnet application with physician analysis, review, and reports


name: Remote interrogation device evaluation of dual lead pacemaker system with interim analysis, reviews, and report by other qualified health care professional


name: Remote interrogation device evaluation of dual lead pacemaker system with interim analysis, reviews, and report by physician


name: Remote interrogation device evaluation of multiple lead pacemaker system with interim analysis, reviews, and report by other qualified health care professional


name: Remote interrogation device evaluation of multiple lead pacemaker system with interim analysis, reviews, and report by physician


name: Remote interrogation device evaluation of single lead pacemaker system with interim analysis, reviews, and report by other qualified health care professional


name: Remote interrogation device evaluation of single lead pacemaker system with interim analysis, reviews, and report by physician


name: Remote interrogation device evaluation up to 90 days of dual lead implantable cardioverter-defibrillator system with interim other qualified health care professional analysis, reviews, and reports


name: Remote interrogation device evaluation up to 90 days of dual lead implantable cardioverter-defibrillator system with interim physician analysis, reviews, and reports


name: Remote interrogation device evaluation up to 90 days of multiple lead implantable cardioverter-defibrillator system with interim other qualified health care professional analysis, reviews, and reports


name: Remote interrogation device evaluation up to 90 days of multiple lead implantable cardioverter-defibrillator system with interim physician analysis, reviews, and reports


name: Remote interrogation device evaluation up to 90 days of single lead implantable cardioverter-defibrillator system with interim other qualified health care professional analysis, reviews, and reports


name: Remote interrogation device evaluation up to 90 days of single lead implantable cardioverter-defibrillator system with interim physician analysis, reviews, and reports


name: Remote interrogation device evaluation up to 90 days of dual lead pacemaker system with remote data acquisition, receipt of transmissions and technician review, technical support, and distribution of results


name: Remote interrogation device evaluation up to 90 days of implantable cardioverter-defibrillator system with remote data acquisition, receipt of transmissions and technician review, technical support, and distribution of results


name: Remote interrogation device evaluation up to 90 days of leadless pacemaker system with remote data acquisition, receipt of transmissions and technician review, technical support, and distribution of results


name: Remote interrogation device evaluation up to 90 days of multiple lead pacemaker system with remote data acquisition, receipt of transmissions and technician review, technical support, and distribution of results


name: Remote interrogation device evaluation up to 90 days of single lead pacemaker system with remote data acquisition, receipt of transmissions and technician review, technical support, and distribution of results


name: Remote interrogation device evaluation up to 30 days of implantable cardiovascular physiologic monitor system with analysis, review, and report, with analysis of recorded physiologic cardiovascular data elements from internal and external sensors, by other qualified health care professional


name: Remote interrogation device evaluation up to 30 days of implantable cardiovascular physiologic monitor system with analysis, review, and report, with analysis of recorded physiologic cardiovascular data elements from internal and external sensors, by physician


name: Remote interrogation device evaluation of up to 30 days of subcutaneous cardiac rhythm monitor system with analysis, review, and report, with analysis of recorded physiologic cardiovascular data elements from internal and external sensors, by other qualified health care professional


name: Remote interrogation device evaluation of up to 30 days of subcutaneous cardiac rhythm monitor system with analysis, review, and report, with analysis of recorded physiologic cardiovascular data elements from internal and external sensors, by physician


name: Follow-up transthoracic echocardiography for congenital cardiac anomalies


name: Limited transthoracic echocardiography for congenital cardiac anomalies


name: Real time transthoracic echocardiography with 2-dimensional (2D) image documentation, M-mode recording with spectral Doppler echocardiography, and color flow Doppler echocardiography


name: Real time transthoracic echocardiography with 2-dimensional (2D) image documentation, spectral Doppler echocardiography, and color flow Doppler echocardiography


name: Complete real time transthoracic echocardiography with 2-dimensional (2D) image documentation


name: Complete real time transthoracic echocardiography with 2-dimensional (2D) image documentation and M-mode recording


name: Follow-up real time transthoracic echocardiography with 2-dimensional (2D) image documentation


name: Follow-up real time transthoracic echocardiography with 2-dimensional (2D) image documentation and M-mode recording


name: Limited real time transthoracic echocardiography with 2-dimensional (2D) image documentation


name: Limited real time transthoracic echocardiography with 2-dimensional (2D) image documentation and M-mode recording


name: Real time transesophageal echocardiography with 2-dimensional (2D) image documentation, M-mode recording, probe placement, image acquisition, interpretation, and report


name: Real time transesophageal echocardiography with 2-dimensional (2D) image documentation, probe placement, image acquisition, interpretation, and report


name: Real time transesophageal echocardiography with 2-dimensional (2D) image documentation and placement of transesophageal probe only


name: Real time transesophageal echocardiography with 2-dimensional (2D) image documentation), M-mode recording and placement of transesophageal probe only


name: Interpretation and report only of real time transesophageal echocardiography with 2-dimensional (2D) image documentation and image acquisition


name: Transesophageal echocardiography (TEE) with probe placement, image acquisition, interpretation, and report


name: Transesophageal echocardiography (TEE) for placement of transesophageal probe only


name: Interpretation and report only of transesophageal echocardiography (TEE) with image acquisition


name: Real time transesophageal echocardiography (TEE) with probe placement, 2-dimensional (2D) image acquisition and interpretation


name: Complete continuous wave with spectral display of Doppler echocardiography


name: Complete pulsed wave and continuous wave with spectral display of Doppler echocardiography


name: Complete pulsed wave with spectral display of Doppler echocardiography


name: Follow-up continuous wave with spectral display of Doppler echocardiography


name: Follow-up pulsed wave and continuous wave with spectral display of Doppler echocardiography


name: Follow-up pulsed wave with spectral display of Doppler echocardiography


name: Limited continuous wave with spectral display of Doppler echocardiography


name: Limited pulsed wave and continuous wave with spectral display of Doppler echocardiography


name: Limited pulsed wave with spectral display of Doppler echocardiography


name: Real time transthoracic echocardiography with 2-dimensional (2D) image documentation during rest and cardiovascular stress test using treadmill and pharmacologically induced stress, with interpretation and report


name: Real time transthoracic echocardiography with 2-dimensional (2D) image documentation during rest and cardiovascular stress test using treadmill, bicycle exercise and pharmacologically induced stress, with interpretation and report


name: Real time transthoracic echocardiography with 2-dimensional (2D) image documentation, includes M-mode recording during rest and cardiovascular stress test using treadmill and pharmacologically induced stress, with interpretation and report


name: Real time transthoracic echocardiography with 2-dimensional (2D) image documentation, includes M-mode recording during rest and cardiovascular stress test using treadmill, bicycle exercise and pharmacologically induced stress, with interpretation and report


name: Real time transthoracic echocardiography with 2-dimensional (2D) image documentation during rest and cardiovascular stress test using treadmill, bicycle exercise and pharmacologically induced stress, with interpretation and report, including performance of continuous electrocardiographic monitoring, with physician supervision


name: Real time transthoracic echocardiography with 2-dimensional (2D) image documentation during rest and cardiovascular stress test using treadmill, bicycle exercise induced stress, with interpretation and report, including performance of continuous electrocardiographic monitoring, with physician supervision


name: Real time transthoracic echocardiography with 2-dimensional (2D) image documentation during rest and cardiovascular stress test using treadmill, pharmacologically induced stress, with interpretation and report, including performance of continuous electrocardiographic monitoring, with physician supervision


name: Real time transthoracic echocardiography with 2-dimensional (2D) image documentation, includes M-mode recording during rest and cardiovascular stress test using treadmill, bicycle exercise and pharmacologically induced stress, with interpretation and report, including performance of continuous electrocardiographic monitoring, with physician supervision


name: Real time transthoracic echocardiography with 2-dimensional (2D) image documentation, includes M-mode recording during rest and cardiovascular stress test using treadmill, bicycle exercise induced stress, with interpretation and report, including performance of continuous electrocardiographic monitoring, with physician supervision


name: Real time transthoracic echocardiography with 2-dimensional (2D) image documentation, includes M-mode recording during rest and cardiovascular stress test using treadmill, pharmacologically induced stress, with interpretation and report, including performance of continuous electrocardiographic monitoring, with physician supervision


name: Transesophageal echocardiography (TEE) for guidance of transcatheter closure of left atrial appendage, with quantitative measurements, probe manipulation, interpretation and report


name: Transesophageal echocardiography (TEE) for guidance of transcatheter closure of ventricular septal defect, with quantitative measurements, probe manipulation, interpretation and report


name: Transesophageal echocardiography (TEE) for guidance of transcatheter great vessel structural intervention, with quantitative measurements, probe manipulation, interpretation and report


name: Transesophageal echocardiography (TEE) for guidance of transcatheter intracardiac structural intervention, with quantitative measurements, probe manipulation, interpretation and report


name: Transesophageal echocardiography (TEE) for guidance of transcatheter mitral valve repair, with quantitative measurements, probe manipulation, interpretation and report


name: Transesophageal echocardiography (TEE) for guidance of transcatheter occlusion of left atrial appendage, with quantitative measurements, probe manipulation, interpretation and report


name: Transesophageal echocardiography (TEE) for guidance of transcatheter repair of paravalvular regurgitation, with quantitative measurements, probe manipulation, interpretation and report


name: Transesophageal echocardiography (TEE) for guidance of transcatheter replacement of aortic valve replacement, with quantitative measurements, probe manipulation, interpretation and report


name: Transesophageal echocardiography (TEE) for guidance of transcatheter replacement of pulmonary valve, with quantitative measurements, probe manipulation, interpretation and report


name: Right heart catheterization with measurement of oxygen saturation and cardiac output


name: Left heart catheterization with intraprocedural injection for left ventriculography


name: Left heart catheterization with intraprocedural injection for left ventriculography, imaging supervision, and interpretation


name: Combined right and left heart catheterization with intraprocedural injection for left ventriculography


name: Combined right and left heart catheterization with intraprocedural injection for left ventriculography, imaging supervision, and interpretation


name: Catheter placement in coronary artery for coronary angiography, with intraprocedural injection for coronary angiography, imaging supervision, and interpretation


name: Catheter placement in coronary artery for coronary angiography, with intraprocedural injection for coronary angiography, imaging supervision, and interpretation, with catheter placement in bypass graft, with intraprocedural injections for bypass graft angiography


name: Catheter placement in coronary artery for coronary angiography, with intraprocedural injection for coronary angiography, imaging supervision, and interpretation, with right heart catheterization


name: Catheter placement in coronary artery for coronary angiography, with intraprocedural injection for coronary angiography, imaging supervision, and interpretation, with catheter placement in bypass graft, with intraprocedural injection for bypass graft angiography and right heart catheterization


name: Catheter placement in coronary artery for coronary angiography, with intraprocedural injection for coronary angiography, imaging supervision, and interpretation, with left heart catheterization, with intraprocedural injection for left ventriculography


name: Catheter placement in coronary artery for coronary angiography, with intraprocedural injection for coronary angiography, imaging supervision and interpretation, with left heart catheterization, catheter placement in bypass graft, with bypass graft angiography


name: Catheter placement in coronary artery for coronary angiography, with intraprocedural injection for coronary angiography, imaging supervision, and interpretation, with left heart catheterization, with intraprocedural injection for left ventriculography, catheter placement in bypass graft, with bypass graft angiography


name: Catheter placement in coronary artery for coronary angiography, with intraprocedural injection for coronary angiography, imaging supervision, and interpretation, with right and left heart catheterization


name: Catheter placement in coronary artery for coronary angiography, with intraprocedural injection for coronary angiography, imaging supervision, and interpretation, with right and left heart catheterization, with intraprocedural injection for left ventriculography


name: Catheter placement in coronary artery for coronary angiography, with intraprocedural injection for coronary angiography, imaging supervision, and interpretation, with right and left heart catheterization, catheter placement in bypass graft, with bypass graft angiography


name: Catheter placement in coronary artery for coronary angiography, with intraprocedural injection for coronary angiography, imaging supervision, and interpretation, with right and left heart catheterization, with intraprocedural injection for left ventriculography, catheter placement in bypass graft, with bypass graft angiography


name: Pharmacologic agent administration with assessing hemodynamic measurements before, during, after, and repeat pharmacologic agent administration


name: Physiologic exercise study with assessing hemodynamic measurements before and after


name: Injection procedure during cardiac catheterization with imaging supervision, interpretation, and report, for selective coronary angiography during congenital heart catheterization


name: Injection procedure during cardiac catheterization with imaging supervision, interpretation, and report, for selective opacification of aortocoronary arterial bypass graft


name: Injection procedure during cardiac catheterization with imaging supervision, interpretation, and report, for selective opacification of aortocoronary venous bypass graft


name: Injection procedure during cardiac catheterization with imaging supervision, interpretation, and report, for selective left atrial angiography


name: Injection procedure during cardiac catheterization with imaging supervision, interpretation, and report, for selective left ventricular angiography


name: Injection procedure during cardiac catheterization with imaging supervision, interpretation, and report, for selective right atrial angiography


name: Injection procedure during cardiac catheterization with imaging supervision, interpretation, and report, for selective right ventricular angiography


name: Injection procedure during cardiac catheterization with imaging supervision, interpretation, and report, for supravalvular aortography


name: Intravascular Doppler pressure derived coronary flow reserve measurement of initial coronary graft during coronary angiography with pharmacologically induced stress


name: Intravascular Doppler pressure derived coronary flow reserve measurement of initial coronary vessel during coronary angiography with pharmacologically induced stress


name: Intravascular Doppler velocity and pressure derived coronary flow reserve measurement of initial coronary graft during coronary angiography with pharmacologically induced stress


name: Intravascular Doppler velocity and pressure derived coronary flow reserve measurement of initial coronary vessel during coronary angiography with pharmacologically induced stress


name: Intravascular Doppler velocity coronary flow reserve measurement of initial coronary graft during coronary angiography with pharmacologically induced stress


name: Intravascular Doppler velocity coronary flow reserve measurement of initial coronary vessel during coronary angiography with pharmacologically induced stress


name: Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel


name: Intravascular Doppler pressure derived coronary flow reserve measurement of each additional coronary graft during coronary angiography with pharmacologically induced stress


name: Intravascular Doppler pressure derived coronary flow reserve measurement of each additional coronary vessel during coronary angiography with pharmacologically induced stress


name: Intravascular Doppler velocity and pressure derived coronary flow reserve measurement of each additional coronary graft during coronary angiography with pharmacologically induced stress


name: Intravascular Doppler velocity and pressure derived coronary flow reserve measurement of each additional coronary vessel during coronary angiography with pharmacologically induced stress


name: Intravascular Doppler velocity coronary flow reserve measurement of each additional coronary graft during coronary angiography with pharmacologically induced stress


name: Intravascular Doppler velocity coronary flow reserve measurement of each additional coronary vessel during coronary angiography with pharmacologically induced stress


name: Percutaneous transcatheter septal reduction therapy with placement of temporary pacemaker


name: Percutaneous transcatheter closure of paravalvular leak of mitral valve using initial occlusion device


name: Percutaneous transcatheter closure of paravalvular leak, each additional occlusion device


name: Intracardiac electrophysiologic 3-dimensional (3D) mapping


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with right atrial pacing and recording, right ventricular pacing and recording, and His bundle recording


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with attempted induction of arrhythmia, with right atrial pacing and recording, right ventricular pacing and recording, and His bundle recording


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with induction of arrhythmia, with right atrial pacing and recording, right ventricular pacing and recording, and His bundle recording


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with attempted induction of arrhythmia, with left atrial pacing and recording from coronary sinus


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with attempted induction of arrhythmia, with left atrial pacing and recording from left atrium


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with induction of arrhythmia, with left atrial pacing and recording from coronary sinus